Jefferies Starts Unilife Corporation (UNIS) at Buy

Jefferies initiates coverage on Unilife Corporation (NASDAQ: UNIS) with a Buy. PT $7.00.

The firm comments, "Unilife has positioned itself at the intersection of injectable pharmaceuticals and medical devices. The company is poised to unlock value by optimizing delivery of large molecule drugs and extending the lifecycle of off patent pharmaceuticals. Several contracts are close to final and the outlook is exceedingly compelling: we model revenues approaching $500mn in FY16."

For an analyst ratings summary and ratings history on Unilife Corporation click here. For more ratings news on Unilife Corporation click here.

Shares of Unilife Corporation closed at $3.24 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies Starts Aehr Test Systems (AEHR) at Buy
• BMO Capital Starts Energy Fuels (UUUU) at Outperform
• Evercore ISI Starts Alvotech SA (ALVO) at Outperform